Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results in Non-Human Primates Vaccinated with TNX-1800 and Challenged with Live SARS-CoV-2

NEXT STORY
Codiak BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress
PREV STORY
Guidewire Market to Reach USD 1,401.0 Million at 5.9% CAGR; Growing Rate of Coronary Surgeries to Bolster Sales Opportunities: Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mateon Announces New Preclinical Data Demonstrating Enhanced Tumor Immune Responses when CA4P is Given in Combination with Checkpoint Inhibitors

· CA4P and checkpoint inhibitor combination nearly doubles amount of tumor necrosis SOUTH SAN FRANCISCO, ...

author_avatar
NASDAQ Market News

Rexahn Effects 1-for-10 Reverse Stock Split

ROCKVILLE, Md., May 05, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) (“Rexahn” ...

author_avatar
NASDAQ Market News

AZ agreement with Aralez for Toprol-XL in US

This announcement contains inside information 4 October 2016 07:05 ASTRAZENECA ENTERS AGREEMENT WITH ARALEZ ...

author_avatar
NASDAQ Market News